InvestorsHub Logo
Followers 58
Posts 10324
Boards Moderated 1
Alias Born 09/21/2016

Re: hnbadger1 post# 368494

Monday, 08/01/2022 9:14:52 AM

Monday, August 01, 2022 9:14:52 AM

Post# of 470182
Study of the Mechanism of Action of Blarcamesine(ANAVEX®2-73): Whole Blood Transcriptomics Analysis (RNAseq) Identifies Treatment Impact on Compensatory Pathways by Restoring Key Neurodegenerative Pathways Functionality, including Alzheimer’s and Parkinson’s Disease Pathways C. Williams1, M. Kindermans1,F. Parmentier1, F. Goodsaid1, E. Hammond2, C. Missling2, M. Afshar1 1Ariana Pharma, Paris, France, 2Anavex Life Sciences, New York, NY, USA

https://www.npr.org/sections/health-shots/2022/08/01/1113825311/alzheimers-researchers-are-looking-beyond-plaques-and-tangles-for-new-treatments



Turns out the DOT analogy was right all along.(so many dots, so little time)..Those DOTS are actually Genes as shown in this diagram. Nice, when a plan comes together.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News